Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Liver transplantation

• Publication date

  2009-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/lt.21920PMID 19938140
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Conversion to everolimus monotherapy in maintenance liver transplantation: feasibility, safety, and impact on renal function

  2009influential reference
• Determination of everolimus in whole blood using the Abbott IMx sirolimus microparticle enzyme immunoassay.

  2007cited by this paper
• Mycophenolate mofetil in combination with reduction of calcineurin inhibitors for chronic renal dysfunction after liver transplantation

  2006cited by this paper
• Safety, tolerability, and efficacy of everolimus in de novo liver transplant recipients: 12‐ and 36‐month results

  2006cited by this paper
• Sirolimus conversion after liver transplantation: improvement in measured glomerular filtration rate after 2 years.

  2005cited by this paper
• Renal Histopathological Lesions After Orthotopic Liver Transplantation (OLT)

  2005cited by this paper
• Everolimus (certican) in heart transplantation: optimizing renal function through minimizing cyclosporine exposure.

  2005cited by this paper
• Everolimus with Optimized Cyclosporine Dosing in Renal Transplant Recipients: 6‐Month Safety and Efficacy Results of Two Randomized Studies

  2004cited by this paper
• Post‐liver transplant acute renal failure: factors predicting development of end‐stage renal disease *

  2004cited by this paper
• Independent risk factors and natural history of renal dysfunction in liver transplant recipients

  2003cited by this paper
• Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients.

  2003cited by this paper
• Renal function improves in liver transplant recipients when switched from a calcineurin inhibitor to sirolimus

  2003cited by this paper
• Chronic renal dysfunction after liver transplantation in adult patients: prevalence, risk factors, and impact on mortality.

  2003cited by this paper
• Chronic renal failure after transplantation of a nonrenal organ.

  2003cited by this paper
• Sirolimus therapy in orthotopic liver transplant recipients with calcineurin inhibitor related chronic renal insufficiency.

  2003cited by this paper
• Sirolimus monotherapy in nephrotoxicity due to calcineurin inhibitors in liver transplant recipients

  2003cited by this paper
• Sirolimus-based immunosuppresive protocol for calcineurin sparing in liver transplantation

  2002cited by this paper
• K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

  2002cited by this paper
• End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of development and treatment.

  2001cited by this paper
• A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation

  1999cited by this paper
• What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1000 patients.

  1999cited by this paper
• Chronic renal failure following liver transplantation: a retrospective analysis.

  1998cited by this paper
• Predicting glomerular function from adjusted serum creatinine.

  1992cited by this paper

• Ongoing and Novel Challenges in Kidney Transplantation: Therapeutic Approaches to Non-Immunological Risk Factors for Allograft Loss.

  2026cites this paper
• Clinical progression and predictors of renal outcomes following liver transplantation: long-term follow-up results from a Taiwanese center

  2025cites this paper
• AASLD AST Practice Guideline on adult liver transplantation: Diagnosis and post-transplant management of non-graft-related complications.

  2025cites this paper
• A Systematic Review of Kidney Disease Pre- and Post-liver Transplantation

  2024cites this paper
• S2k-Leitlinie Lebertransplantation der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV)

  2024cites this paper
• Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients

  2023cites this paper
• [Kidney failure after liver transplantation].

  2022cites this paper
• Current aspects of renal dysfunction after liver transplantation

  2022cites this paper
• Malignancies and Pediatric Liver Transplantation: Promising Management with the mTOR-inhibitor Everolimus

  2021cites this paper
• Kidney disease in children with heart or liver transplant

  2021cites this paper
• Kidney Failure after Liver Transplantation

  2021cites this paper
• Post‐liver transplantation chronic kidney disease is associated with increased cardiovascular disease risk and poor survival

  2021cites this paper
• Immunosuppressive regimens for adult liver transplant recipients in real-life practice: consensus recommendations from an Italian Working Group

  2020cites this paper
• Metabolic and Renal Effects of Mammalian Target of Rapamycin Inhibitors Treatment After Liver Transplantation: Real-Life Single-Center Experience.

  2020cites this paper
• Renal disease in the allograft recipient.

  2020cites this paper
• Time to Conversion to an Everolimus‐Based Regimen: Renal Outcomes in Liver Transplant Recipients From the EVEROLIVER Registry

  2020cites this paper
• Long-term Management of the Adult Liver Transplantation Recipients.

  2020cites this paper
• Liver Transplantation: Prevention and Treatment of Rejection

  2019cites this paper
• Very Early Introduction of Everolimus in De Novo Liver Transplantation: Results of a Multicenter, Prospective, Randomized Trial

  2019cites this paper
• Effect of cyclosporin and tacrolimus on kidney function in liver recipients

  2018cites this paper
• Cost Analysis and Determinants of Living Donor Liver Transplantation in Taiwan.

  2018cites this paper
• Cardiovascular Disease Outcomes Related to Early Stage Renal Impairment After Liver Transplantation

  2018cites this paper
• Prevalence and progression of chronic kidney disease after liver transplant: a prospective, real-life, observational, two-year multicenter study.

  2018cites this paper
• International Liver Transplantation Society Consensus Statement on Immunosuppression in Liver Transplant Recipients.

  2018cites this paper
• Recommendations of everolimus use in liver transplant.

  2017cites this paper
• Modification of immunosuppressive therapy as risk factor for complications after liver transplantation.

  2017cites this paper
• Everolimus with early withdrawal or reduced‐dose calcineurin inhibitors improves renal function in liver transplant recipients: A systematic review and meta‐analysis

  2017cites this paper
• Use of everolimus in liver transplantation

  2017cites this paper
• Management of Immunosuppression in Liver Transplantation.

  2017cites this paper
• Recommendations of everolimus use in liver transplant.

  2017cites this paper
• Применение эверолимуса после трансплантации печени в реальной клинической практике по данным одного центра

  2017cites this paper
• Disfuncion renal crónica postrasplante hepático

  2016cites this paper
• Use of Everolimus in Liver Transplantation: Recommendations From a Working Group

  2016cites this paper
• Protecting the Kidney in Liver Transplant Recipients: Practice‐Based Recommendations From the American Society of Transplantation Liver and Intestine Community of Practice

  2016cites this paper
• Use of everolimus in liver transplantation: The French experience.

  2016cites this paper
• Lipids in liver transplant recipients.

  2016cites this paper
• EASL Clinical Practice Guidelines: Liver transplantation.

  2016cites this paper
• Everolimus in de novo liver transplant recipients: a systematic review.

  2015cites this paper
• Renal function improvement in liver transplant recipients after early everolimus conversion: A clinical practice cohort study in Spain

  2015cites this paper
• Evaluating the efficacy, safety and evolution of renal function with early initiation of everolimus-facilitated tacrolimus reduction in de novo liver transplant recipients: Study protocol for a randomized controlled trial

  2015cites this paper
• Renal function improvement in liver transplant recipients after early everolimus conversion: A clinical practice cohort study in Spain

  2015cites this paper
• Medical Disease After Abdominal Solid Organ Transplantation and the Risk of Solid and Hematologic Malignant Tumor After Transplantation

  2015cites this paper
• Insuffisance rénale aiguë et chronique au décours de la transplantation d’organe, rein exclu

  2015cites this paper
• Incidence, risk factor, and prognosis of end-stage renal disease after heart transplantation in Chinese recipients.

  2014cites this paper
• Everolimus in liver transplantation

  2014cites this paper
• Tacrolimus and Everolimus de novo versus minimization of standard dosage of Tacrolimus provides a similar renal function at one year after liver transplantation: a case-control matched-pairs analysis.

  2014cites this paper
• [Early detection, prevention and management of renal failure in liver transplantation].

  2014cites this paper
• Detección precoz, prevención y manejo de la insuficiencia renal en el trasplante hepático

  2014cites this paper
• Multiple indications for everolimus after liver transplantation in current clinical practice.

  2014cites this paper
• The role of mTOR inhibitors in the prevention of organ rejection in adult liver transplant patients: a focus on everolimus

  2014cites this paper
• The Role of mTOR Inhibitors in Liver Transplantation: Reviewing the Evidence

  2014cites this paper
• Everolimus monotherapy or combined therapy in liver transplantation: indications and results.

  2013cites this paper
• Calcineurin inhibitors in liver transplantation – still champions or threatened by serious competitors?

  2013cites this paper
• Strategies to prevent or reduce acute and chronic kidney injury in liver transplantation

  2012cites this paper
• A comprehensive review of everolimus clinical reports: a new mammalian target of rapamycin inhibitor.

  2012cites this paper
• Renal Comorbidity After Solid Organ and Stem Cell Transplantation

  2012cites this paper
• Renal dysfunction and the liver transplant recipient; novel strategies for determination of reversibility and renal protective therapies pretransplant and posttransplant

  2012cites this paper
• [Renal co-morbidity after solid organ transplantation].

  2012cites this paper
• Renale Ko-Morbidität nach Transplantation solider Organe

  2012cites this paper
• Simultaneous pancreas-kidney transplantation nine years after liver transplantation--a case report.

  2012cites this paper
• Hot‐topic debate on kidney function: Renal‐sparing approaches are beneficial

  2011cites this paper
• Calcineurin inhibitors in liver transplantation: to be or not to be.

  2011cites this paper
• Conversion to everolimus in liver transplant patients with renal dysfunction.

  2011cites this paper
• Immunosuppression in liver transplant recipients with renal impairment.

  2011cites this paper
• The use of everolimus in pediatric liver transplant recipients: First experience in a single center

  2011cites this paper
• Management of renal dysfunction in patients receiving a liver transplant.

  2011cites this paper
• Lymphocytes T régulateurs et Transplantation hépatique : modulation de l'activité des lymphocytes T régulateurs CD4+CD25+ par les drogues immunosuppressives

  2011cites this paper
• The Role of Everolimus in Lung and Liver Transplantation

  2011cites this paper
• Everolimus in clinical practice in long-term liver transplantation: an observational study.

  2011cites this paper
• Conversion to everolimus in maintenance liver transplant patients: A multicenter, retrospective analysis

  2011cites this paper
• The future of liver transplantation.

  2010cites this paper
• Improvement in renal function after late conversion to sirolimus-based immunosuppression in composite tissue allotransplantation.

  2010cites this paper
• Current awareness: Pharmacoepidemiology and drug safety

  2010cites this paper
• Renal function in the long term after pediatric liver transplantation: is there a need for protocol kidney biopsies?

  2010cites this paper
• Update from the Spanish Oncology Genitourinary Group on the treatment of advanced renal cell carcinoma: focus on special populations

  2010cites this paper
• Management of takotsubo cardiomyopathy in a lung transplant recipient.

  2010cites this paper
• The challenge of preserving renal function after liver transplantation.

  2009cites this paper